Floatz logo

131 assets in Esophageal Cancer

Therapeutic assets addressing Esophageal Cancer, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Fluorouracilum
Esophageal Cancer
Merck Sharp & Dohme LLCP4BB (65)
Epirubicin
Esophageal Cancer
Sutro Biopharma, Inc.P3B (62)
Pembrolizumab
Esophageal Cancer
Essen BiotechP3B (62)
Capecitabine
Esophageal Cancer
Shenyang Sunshine Pharmaceutical Co., LTD.P2B (61)
Carboplatin
Esophageal Cancer
Neonc Technologies, Inc.P2B (61)
Cyclophosphamide
Esophageal Cancer
Sutro Biopharma, Inc.P3B (61)
Docetaxel
Esophageal Cancer
Laekna LimitedP2B (61)
Cis-Diamminedichloroplatinum Ii
Esophageal Cancer
Shenyang Sunshine Pharmaceutical Co., LTD.P3B (60)
Oxaliplatin
Esophageal Cancer
Shenyang Sunshine Pharmaceutical Co., LTD.P2B (60)
Irinotecan
Esophageal Cancer
Neonc Technologies, Inc.P2B (57)
Lenvatinib
Esophageal Cancer
Merck Sharp & Dohme LLCP2B (57)
Pembrolizumab/Vibostolimab Coformulation
Esophageal Cancer
Merck Sharp & Dohme LLCP2B (57)
Atezolizumab
Esophageal Cancer
National University Hospital, SingaporeP2CCC (54)
Nivolumab
Esophageal Cancer
Diwakar DavarP2CCC (54)
Ssgj-706
Esophageal Cancer
Shenyang Sunshine Pharmaceutical Co., LTD.P2CCC (53)
her3-dxd
Esophageal Cancer
Merck Sharp & Dohme LLCP2CCC (52)
Immunoglobulin G1 [De-448-Lysine], Anti-(Human Epidermal Growth Factor Receptor) (Human-Mouse Monoclonal C225 ?1-Chain) Fusion Protein With Peptide Linker (Ggggs)2 Fusion Protein With Immunoglobulin Anti-(Human Epidermal Growth Factor Receptor Her3) (Human Clone Her3.H3 Single-Chain Variable Fragment Vh-(Ggggs)3-Vl), Complex With Human-Mouse Monoclonal C225 ?-Chain, Dimer, 214??,214???,222,222?,228,228?,231,231?-Octakis(Thioether) With (2S)-N-(Carboxymethyl)-2-(3-Mercapto-2,5-Dioxo-1-Pyrrolidinyl)-?-Alanylglycylglycyl-L-Phenylalanyl-N-[[(1S)-2-[[(1S,9S)-9-Ethyl-5-Fluoro-2,3,9,10,13,15-Hexahydro-9-Hydroxy-4-Methyl-10,13-Dioxo-1H,12H-Benzo[De]Pyrano[3?,4?:6,7]Indolizino[1,2-B]Quinolin-1-Yl]Amino]-1-Methyl-2-Oxoethoxy]Methyl]Glycinamide
Esophageal Cancer
Sichuan Baili Pharmaceutical Co., Ltd.P2CCC (52)
Durvalumab
Esophageal Cancer
Second Affiliated Hospital of Guangzhou Medical UniversityP1/2CCC (49)
Fludarabine
Esophageal Cancer
Chongqing Precision Biotech Co., LtdP1/2CCC (49)
Trastuzumab
Esophageal Cancer
Institut Paoli-CalmettesP1/2CCC (49)
Cbp-1019
Esophageal Cancer
Coherent Biopharma (Hefei) Co., Ltd.P1/2CCC (48)
Enzalutamide
Esophageal Cancer
Cancer Research UKP1/2CCC (48)
Gamma1 Heavy Chain Humanized (1-450) [Vh (Homo Sapiens Ighv4-31*01 (89.9%) -(Ighd) -Ighj4*01 (92.9%), Cdr-Imgt [9.7.13] (26-34.52-58.97-109)) (1-120) -Homo Sapiens Ighg1*01 (100%), G1M17,1 Ch1 K120, D12, L14 (Ch1 K120 (217) (121-218), Hinge 1-15 (219-233), Ch2 (234-343), Ch3 D12 (359), L14 (361) (344-448), Chs (449-450)) (121-450)], (223-214')-Disulfide With Kappa Light Chain Humanized (1'-214') [V-Kappa (Homo Sapiens Igkv1-12*01 (85.3%)-Igkj2*01 (100%), Cdr-Imgt [6.3.9] (27-32.50-52.89-97)) (1'-107') -Homo Sapiens Igkc*01 (100%), Km3 A45.1 (153), V101 (191) (108'-214')]; Dimer (229-229'':232-232'')-Bisdisulfide, Produced In Chinese Hamster Ovary (Cho) Cells, Derived From The Cell Line Cho-K1,Glycoform Alfa
Esophageal Cancer
Cancer Research UKP1/2CCC (48)
Niraparib
Esophageal Cancer
Tempus AIP2CCC (48)
prt3789
Esophageal Cancer
Prelude TherapeuticsP2CCC (48)
Si-B003
Esophageal Cancer
Sichuan Baili Pharmaceutical Co., Ltd.P2CCC (48)
Zanidatamab
Esophageal Cancer
Jazz PharmaceuticalsP2CCC (48)
[68ga]ga-oncofap administration
Esophageal Cancer
Philogen S.p.A.P1CC (47)
htl0039732 capsules
Esophageal Cancer
Cancer Research UKP1/2CC (47)
Levofolinic Acid
Esophageal Cancer
Merck Sharp & Dohme LLCP1/2CC (47)
Patritumab Deruxtecan
Esophageal Cancer
Merck Sharp & Dohme LLCP1/2CC (47)
Sacituzumab Tirumotecan
Esophageal Cancer
Merck Sharp & Dohme LLCP1/2CC (47)
ucb4594
Esophageal Cancer
Cancer Research UKP1/2CC (47)
Cea-Targeted Car-T
Esophageal Cancer
Chongqing Precision Biotech Co., LtdP1/2CC (46)
Immunoglobulin G1, Anti-(Human Vascular Endothelial Growth Factor Receptor Type Vegfr-2 Extracellular Domain) (Human Monoclonal Imc-1121B .Gamma.-Chain), Disulphide With Human Monoclonal Imc-1121B .Kappa.-Chain, Dimer
Esophageal Cancer
Merck Sharp & Dohme LLCP1/2CC (46)
Nadravaleucel
Esophageal Cancer
David WaldP1/2CC (46)
Afuresertib
Esophageal Cancer
Laekna LimitedP1/2CC (44)
H-Gamma1 Heavy Chain Homo Sapiens (1-447) [Vh (Homo Sapiens Ighv4-59*01 (99.0%) -(Ighd) -Ighj3*02 (93.3%) T125>I (114), Cdr-Imgt [8.7.11] (26-33.51-57.96-106)) (1-117) -Homo Sapiens Ighg1*01, G1M17,1 Ch1 K120, Ch3 D12, L14, 9-G1V21 Ch2 Y15.1, T16, E18 (Ch1 K120 (214) (118-215), Hinge 1-15 (216-230), Ch2 M15.1>Y (252), S16>T (254), T18>E (256) (231-340), Ch3 D12 (356), L14 (358) (341-445), Chs (446-447)) (118-447)], (220-214')-Disulfide With L-Kappa Light Chain Homo Sapiens (1'-214') [V-Kappa (Homo Sapiens Igkv3-11*01 (96.8%) -Igkj4*01 (100%), Cdr-Imgt [6.3.9] (27'-32'.50'-52'.89'-97')) (1'-107') -Homo Sapiens Igkc*01 (100%) Km3 A45.1, V101 (Ckappa A45.1 (153'), V101 (191')) (108'-214')]; Dimer (226-226'':229-229'')-Bisdisulfide, Produced In A Cell Line Derived From Chinese Hamster Ovary (Cho) Cells, Glycoform Alfa
Esophageal Cancer
Kineta Inc.P1/2CC (44)
il15-transpresenting wt1-targeted dendritic cell vaccine
Esophageal Cancer
University Hospital, AntwerpP1/2CC (44)
bc008-1a
Esophageal Cancer
Sichuan Luzhou Buchang Biopharmaceutical Co., Ltd.P1CC (43)
Immunoglobulin G1 [De-236-Glycine,267-Glutamic Acid,De-C-Terminal Lysine], Anti-(Human Tumor Necrosis Factor Receptor Tnfrsf9) (Human-Mus Musculus Monoclonal Lvgn6051 ?1-Chain), Disulfide With Human-Mus Musculus Monoclonal Lvgn6051 ?-Chain, Dimer
Esophageal Cancer
M.D. Anderson Cancer CenterP1CC (43)
Immunoglobulin G1 [De-236-Glycine,De-C-Terminal Lysine], Anti-(Human Cd40 Antigen) (Human Monoclonal Lvgn7409 ?1-Chain), Disulfide With Human Monoclonal Lvgn7409 ?-Chain, Dimer
Esophageal Cancer
M.D. Anderson Cancer CenterP1CC (43)
IPH5301
Esophageal Cancer
Institut Paoli-CalmettesP1CC (43)
Lithium, Elemental
Esophageal Cancer
Cancer Trials IrelandP1CC (43)
ly4257496
Esophageal Cancer
Eli Lilly and CompanyP1CC (43)
ly4337713
Esophageal Cancer
Eli Lilly and CompanyP1CC (43)
Pradusinstobart
Esophageal Cancer
M.D. Anderson Cancer CenterP1CC (43)
[203pb]pb-psv359
Esophageal Cancer
Perspective TherapeuticsP1/2CC (41)
[212pb]pb-psv359
Esophageal Cancer
Perspective TherapeuticsP1/2CC (41)
64cu-lnth-1363s
Esophageal Cancer
Lantheus Medical ImagingP1/2CC (41)
Showing 1 to 50 of 131 assets
PreviousPage 1 of 3Next